Gentex (GNTX)
(Delayed Data from NSDQ)
$30.53 USD
+0.22 (0.73%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $30.56 +0.03 (0.10%) 7:58 PM ET
4-Sell of 5 4
B Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$30.53 USD
+0.22 (0.73%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $30.56 +0.03 (0.10%) 7:58 PM ET
4-Sell of 5 4
B Value B Growth F Momentum B VGM
Zacks News
Gentex Q3 Earnings Surpass Expectations, Guidance Revised
by Zacks Equity Research
GNTX reports mixed third-quarter results and expects 2024 net sales in the range of $2.35-$2.40 billion, down from the previous estimate of $2.40-$2.50 billion.
Gentex (GNTX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Gentex (GNTX) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Gentex (GNTX) Tops Q3 Earnings Estimates
by Zacks Equity Research
Gentex (GNTX) delivered earnings and revenue surprises of 6% and 0.46%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Allison Transmission (ALSN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Allison Transmission (ALSN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Exploring Analyst Estimates for Gentex (GNTX) Q3 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Gentex (GNTX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.
Gentex (GNTX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Gentex (GNTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Oshkosh (OSK) Up 1.4% Since Last Earnings Report?
by Zacks Equity Research
Oshkosh (OSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Westport (WPRT) Q2 Earnings Beat Estimates, Sales Decline Y/Y
by Zacks Equity Research
Westport's (WPRT) second-quarter earnings beat the Zacks Consensus Estimate, while revenues miss the same.
DRVN vs. GNTX: Which Stock Is the Better Value Option?
by Zacks Equity Research
DRVN vs. GNTX: Which Stock Is the Better Value Option?
Implied Volatility Surging for Gentex (GNTX) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Gentex (GNTX) stock based on the movements in the options market lately.
Gentex (GNTX) Q2 Earnings Miss Expectations, Guidance Trimmed
by Zacks Equity Research
Gentex (GNTX) reports lower-than-expected second-quarter results and expects 2024 net sales in the range of $2.40-$2.50 billion, down from the previous estimate of $2.45-$2.55 billion.
Here's What Key Metrics Tell Us About Gentex (GNTX) Q2 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Gentex (GNTX) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Gentex (GNTX) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Gentex (GNTX) delivered earnings and revenue surprises of -28.85% and 8.08%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Oshkosh (OSK) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Oshkosh (OSK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BWA vs. GNTX: Which Stock Is the Better Value Option?
by Zacks Equity Research
BWA vs. GNTX: Which Stock Is the Better Value Option?
BWA or GNTX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BWA vs. GNTX: Which Stock Is the Better Value Option?
Bear of the Day: Adient (ADNT)
by Shaun Pruitt
Investors hoping for a rebound in Adient's (ADNT) stock may be disappointed given the downward trend of earnings estimate revisions which still suggests more short-term weakness ahead
BWA vs. GNTX: Which Stock Is the Better Value Option?
by Zacks Equity Research
BWA vs. GNTX: Which Stock Is the Better Value Option?
Lear (LEA) Down 1.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Lear (LEA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Magna (MGA) Stock Down 4% Since Q1 Earnings & Sales Miss
by Zacks Equity Research
Magna (MGA) now expects 2024 revenues in the band of $42.6-$44.2 billion, down from $43.8-$45.4 billion guided earlier.
Autoliv (ALV) Stock Up 7% Since Q1 Earnings & Sales Beat
by Zacks Equity Research
Autoliv (ALV) forecasts full-year 2024 organic sales growth and adjusted operating margin to be around 5% and 10.5%, respectively.
Lear's (LEA) Q1 Earnings Beat, Revenues Match Estimates
by Zacks Equity Research
Lear (LEA) projects its full-year net sales in the band of $24-$24.6 billion, up from $23.5 billion recorded in 2023.
Gentex (GNTX) Q1 Earnings Match Estimates, Increase Y/Y
by Zacks Equity Research
Gentex's (GNTX) first-quarter 2024 earnings match the Zacks Consensus Estimate, while revenues miss the same.
Compared to Estimates, Gentex (GNTX) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Gentex (GNTX) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Gentex (GNTX) Q1 Earnings Meet Estimates
by Zacks Equity Research
Gentex (GNTX) delivered earnings and revenue surprises of 0% and 1.71%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?